Table 2.
Confirmed and new biological activities of azo compounds (11–21) derived from actinomycetes
| No. | Activity reviewed | Activities confirmed (Pa) | Additional predicted activities (Paa) |
|---|---|---|---|
| 11 | Antibiotic anti-mycobacterial | Antibacterial (0.489) | Hepatic disorders treatment (0.733) Antineoplastic (0.731) Antieczematic (0.697) |
| 12 | Antibiotic antifungal cytotoxic | Antifungal (0.646) Antineoplastic (0.738) |
Hepatic disorders treatment (0.763) Vasodilator, peripheral (0.738) |
| 13 | Antibiotic antifungal cytotoxic | Antifungal (0.639) | Vasodilator (0.722) Antiinfective (0.684) Vasodilator (0.637) |
| 14 | Antibiotic cytotoxic | Antineoplastic (0.549) | Phobic disorders treatment (0.769) Antiviral (arbovirus) (0.688) Natural killer cell stimulant (0.637) |
| 15 | Antibiotic cytotoxic | Antineoplastic (0.599) | Hepatic disorders treatment (0.604) Vasodilator, peripheral (0.609) |
| 16 | Antibiotic antibacterial | – | Phobic disorders treatment (0.834) Antiviral (arbovirus) (0.805) Mucositis treatment (0.754) |
| 17 | Antibiotic antibacterial | – | Phobic disorders treatment (0.888) Preneoplastic (0.779) Mucositis treatment (0.756) |
| 18 | Antibiotic antibacterial | – | Phobic disorders treatment (0.837) Mucositis treatment (0.734) Natural killer cell stimulant (0.668) |
| 19 | Nematocide | – | Hepatic disorders treatment (0.849) Phobic disorders treatment (0.672) Antifungal (0.569) |
| 20 | Nematocide | – | Hepatic disorders treatment (0.849) Phobic disorders treatment (0.672) Antifungal (0.569) |
| 21 | Antibiotic antineoplastic | Antineoplastic (0.672) | Antiviral (arbovirus) (0.557) |
aOnly activities with Pa > 0.5 are shown